Drug & intervention

dapagliflozin

RxCUI 1488564

Clinical trials168
Recruiting5
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

40 shown
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusNCT07662044 · 2026-07-06
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06
RECRUITING
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 DiabetesNCT05345327 · 2023-01-01
RECRUITING
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary SyndromesNCT06286878 · 2021-12-08
RECRUITING
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)NCT02969798 · 2014-01-01
RECRUITING
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.NCT06851962 · 2025-05-26
COMPLETED
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 DiabetesNCT06532682 · 2024-07-01
UNKNOWN
Neoadjuvant SGLT2 Inhibition in Localized Prostate CancerNCT04887935 · 2024-06-04
TERMINATED
Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With MetforminNCT06415773 · 2024-06-04
COMPLETED
Anti-Diabetic Medications to Fight PD and LBDNCT06263673 · 2024-05-07
COMPLETED
Efficacy and Safety of LID104 in the Treatment of Type II Diabetes MellitusNCT05886088 · 2024-02-01
NOT_YET_RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminNCT06192108 · 2024-01-10
COMPLETED
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated CirrhosisNCT06147518 · 2023-12-20
UNKNOWN
Obesity Treatment to Improve DiabetesNCT05390307 · 2023-04-01
COMPLETED
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesNCT06127433 · 2023-03-07
UNKNOWN
Dapagliflozin Therapy In Cardiac SurgeryNCT05621551 · 2022-11-11
COMPLETED
Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 DiabetesNCT05591235 · 2022-11-01
UNKNOWN
Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated AlbuminuriaNCT05570305 · 2022-10-06
COMPLETED
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminNCT05505994 · 2022-09-28
UNKNOWN
Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 DiabetesNCT05457933 · 2022-07-29
COMPLETED
Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 DiabetesNCT05139914 · 2022-05-31
TERMINATED
Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)NCT04234867 · 2022-05-18
TERMINATED
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and FulvestrantNCT04899349 · 2022-04-06
TERMINATED
Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.NCT05262257 · 2022-04-01
UNKNOWN
Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single ComponentsNCT05266404 · 2022-03-21
COMPLETED
Cognitive Protective Effect of Newer Antidiabetic DrugsNCT05347459 · 2022-03-02
UNKNOWN
Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic NephropathyNCT05418465 · 2022-01-26
UNKNOWN
Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 DiabetesNCT05194592 · 2022-01-07
UNKNOWN
EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.NCT04743453 · 2021-08-17
COMPLETED
GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation TrialNCT04796428 · 2021-06-30
UNKNOWN
A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 DiabetesNCT04956263 · 2021-06-17
COMPLETED
A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinNCT04706637 · 2021-02-01
UNKNOWN
The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.NCT04634500 · 2020-11-18
COMPLETED
Semaglutide and Dapagliflozin in Diabetic Patients With Different PathophysiologyNCT04451837 · 2020-09-10
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyNCT03499704 · 2020-02-11
COMPLETED
A Phase 2b Diabetic Kidney Disease StudyNCT04170543 · 2019-11-18
COMPLETED
Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes MellitusNCT04014192 · 2019-09-01
UNKNOWN
Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in ObesityNCT03710460 · 2019-07-30
UNKNOWN
Replication of the DECLARE Diabetes Trial in Healthcare ClaimsNCT04215523 · 2019-07-08
COMPLETED
Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes PatientsNCT03982238 · 2019-06-15
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.